ask="6.80"
ask_size="200"
average_daily_volume="310363"
bid="5.70"
bid_size="3300"
book_value="3.69"
change="+0.95"
change_from_200_day_moving_average="-3.95"
change_from_50_day_moving_average="-4.51"
change_from_52_week_high="-8.05"
change_From_52_week_low="2.67"
change_in_percent="+16.96%"
close="6.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.98"
ex_dividend_date="N/A"
float_shares="16060000"
high="7.25"
high_52_weeks="14.60"
last_trade_date="2/3/2017"
last_trade_price="6.55"
last_trade_size="29014"
last_trade_time="4:00pm"
low="5.80"
low_52_weeks="3.88"
market_capitalization="116.89M"
moving_average_200_day="10.50"
moving_average_50_day="11.06"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="29.25"
open="5.95"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-37.63%"
percent_change_from_50_day_moving_average="-40.78%"
percent_change_from_52_week_high="-55.14%"
percent_change_from_52_week_low="+68.81%"
previous_close="5.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.52"
price_per_sales="105.46"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="7.27"
stock_exchange="NCM"
symbol="STML"
volume="1713855"
weeks_range_52="3.88 - 14.60"
